Everything international buyers need to know about sourcing generic medicines from India. Quality, pricing, documentation, regulations. Updated 2025.
India accounts for approximately 20% of global generic medicine supply by volume. Known as the "pharmacy of the world," India exported pharmaceutical products worth USD 27.8 billion in 2023–24, supplying medicines to over 200 countries. For international buyers — distributors, importers, hospital procurement departments, and NGO procurement teams — India offers an unmatched combination of quality, diversity, and price advantage.
India's pharmaceutical industry advantages are structural and well-established:
| Category | India's Global Market Share | Key Products |
|---|---|---|
| Antiretrovirals (ARVs) | ~80% of global supply | Tenofovir, Lamivudine, Efavirenz |
| Antimalarials | ~70% of global ACT supply | Artemether-Lumefantrine, Artesunate |
| Antibiotics | ~25% of global generics | Amoxicillin, Azithromycin, Ciprofloxacin |
| ED Medicines | ~60% of global generic supply | Sildenafil, Tadalafil, Vardenafil |
| Oncology generics | ~30% of global generics | Imatinib, Sorafenib, Erlotinib |
| Vaccines | ~60% of WHO-procured vaccines | DPT, OPV, Measles, COVID-19 |
WHO-GMP (World Health Organization Good Manufacturing Practice) is the international benchmark for pharmaceutical manufacturing quality. A WHO-GMP certificate means the manufacturing facility has been inspected and certified to produce medicines that are:
NishJay HealthCare India sources exclusively from WHO-GMP certified, CDSCO-approved manufacturers. This is the minimum standard we accept in our supply chain.
WHO-GMP certified pharmaceutical exporter from Nagpur, India. 4,128+ products. Complete export documentation. 24-hour quotation response.